Medium materiality6/10
Iovance Biotherapeutics resumed with a Buy at Goldman Sachs
Why it may matterVerify against the original reporting
Upside potential from analyst upgrade.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs targets $15; current price about $10.19.
- Goldman Sachs: Buy target 15; price 10.19
Key facts
- 01
Target: $15
- 02
Posted price: $10.19
- 03
Analyst firm: Goldman Sachs
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.